Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group

Pharmacotherapy

Volumn 24, Issue 7 I, 2004, Pages 856-870

  Brackett, Carolyn C ^a   Singh, Harleen ^b   Block, John H ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Cross allergenicity; Cross reactivity; Cytotoxicity; Sulfonamide; T cell

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; AMINOPHYLLINE; AMOXICILLIN; ANTIBIOTIC AGENT; BUMETANIDE; CAPTOPRIL; CELECOXIB; CHLOROTHIAZIDE; CLOPIDOGREL; COTRIMOXAZOLE; ETACRYNIC ACID; FUNCTIONAL GROUP; FUROSEMIDE; GLIBENCLAMIDE; GRISEOFULVIN; HETEROCYCLIC COMPOUND; HYDROCHLOROTHIAZIDE; NITROGEN; OMEPRAZOLE; PENICILLAMINE; RANITIDINE; SPIRONOLACTONE; STEROID; SULFONAMIDE; SULFUR DIOXIDE; SULINDAC; TORASEMIDE; TRIMETHOPRIM; UNINDEXED DRUG;

ADVERSE DRUG REACTION; ANAPHYLAXIS; BLOOD DYSCRASIA; CROSS ALLERGY; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DRUG CYTOTOXICITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DYSPNEA; EDEMA; EOSINOPHILIA; EPIDERMOLYSIS; ERYTHEMA; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; FACE EDEMA; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMOLYTIC ANEMIA; HUMAN; HYPERSENSITIVITY REACTION; HYPOGLYCEMIA; IDIOSYNCRATIC REACTION; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE COMPLEX DISEASE; IMMUNE SYSTEM; KIDNEY TUBULE ACIDOSIS; LEUKOCYTOCLASTIC VASCULITIS; LUPUS ERYTHEMATOSUS; METABOLITE; MOLECULAR RECOGNITION; NECK SWELLING; NEUROLOGIC DISEASE; PAPULE; PATHOPHYSIOLOGY; RASH; REVIEW; SERUM SICKNESS; SKIN MANIFESTATION; STEREOSPECIFICITY; STEVENS JOHNSON SYNDROME; STRUCTURE ACTIVITY RELATION; SULFONAMIDE HYPERSENSITIVITY SYNDROME; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS; URTICARIA;

AGED; ANTI-BACTERIAL AGENTS; CROSS REACTIONS; DRUG HYPERSENSITIVITY; HUMANS; MALE; MIDDLE AGED; STEREOISOMERISM; SULFONAMIDES;

EID: 3042819020     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.9.856.36106     Document Type: Review

References (41)

1. Tilles S. Practical issues in the management of hypersensitivity reactions: sulfonamides. South Med J 2001;94:817-24.
2. Allen J. Which medications to avoid in patients with sulfa allergy? Pharmacist's Letter 2000;16:1-2.
3. Gruchalla RS. Diagnosis of allergic reactions to sulfonamides. Allergy 1999;54:28-32.
4. Kucera C, Greenberger P. Adverse drug reactions: treatment and prevention. Hosp Med 1996;32:11-24.
5. Wall GC, Bigner D, Craig S. Ethacrynic acid and the sulfa-sensitive patient. Arch Intern Med 2003;163:116-17.
6. Bukhalo M, Zeitouni NC, Cheney RT. Leukocytoclastic vasculitis induced by use of glyburide: a case of possible cross-reaction of a sulfonamide and a sulfonylurea. Cutis 2003;3:235-8.
7. Ernst EJ, Egge JA. Celecoxib-induced erythema multiforme with glyburide cross-reactivity. Pharmacotherapy 2002;22:637-40.
8. World Health Organization. World Health Organization international drug monitoring: the role of the hospital. Technical report series no. 425. Geneva, Switzerland: World Health Organization, 1966.
9. Cribb AE, Lee B, Trepanier L, Spielberg SP. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev 1996;15:9-10.
10. Markowitz N, Saravolatz LD. Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient population. Rev Infect Dis 1987;9:S218-29.
11. Bedard K, Smith S, Cribb A. Sequential assessment of an antidrug antibody response in a patient with a systemic delayed-onset sulphonamide hypersensitivity syndrome reaction. Br J Dermatol 2000;142:253-8.
12. Knowles S, Shapiro L, Shear N. Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of "sulfa" allergy. Drug Safety 2001;24:239-47.
13. Tunnicliffe WS, Harrison RM, Kelly FJ, Dunster C, Ayres JG. The effect of sulphurous air pollutant exposures on symptoms, lung function, exhaled nitric oxide, and nasal epithelial lining fluid antioxidant concentrations in normal and asthmatic adults [online exclusive article]. Occup Environ Med 2003;60:e15. Available from www.oem.bmjjournals.com.
14. Kitamura K, Aihara M, Osawa J, Naito S, Ikezawa Z. Sulfhydryl drug-induced eruption: a clinical and histological study. J Dermatol 1990;17:44-51.
15. Golembiewski JA. Allergic reactions to drugs: implications for perioperative care. J Perianesth Nurs 2002;17:393-8.
16. Sainte-Laudy J, Vallon C, Guerin JC. Demonstration of sulfite-group-specific IgE in patients with intolerance to preservatives. Allerg Immunol 1994;26(4):132-4, 137-8.
17. Klinker KP, Harbilas JW, Johns TE. Drug-induced hematologic disorders. In: DiPiro J, Talbert R, Yee G, Matzke G, Wells B, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach, 5th ed. New York: McGraw-Hill, 2002:1783-95.
18. Kuby J, ed. Hypersensitivity reactions. In: Immunology, 3rd ed. Philadelphia: WH Freeman and Co., 1997:413-39.
19. Leyva L, Torres MJ, Posadas S, et al. Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response. J Allergy Clin Immunol 2000;105:157-65.
20. Fritsch PO, Sidoroff A. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol 2000;1(6):349-60.
21. Fox RW. Best practice of medicine: cutaneous drug reactions. Available from http://merck.praxis.md/index.asp?page=bpm_ author&article_id=B? MO1DE15&author=1. Accessed August 2, 2003.
22. Harle DG, Baldo BA, Wells JV. Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole. Molecular Immunol 1988;25:1347-54.
23. Carrington DM, Early HS, Sullivan TJ. Studies of human IgE to a sulfonamide determinant. J Allergy Clin Immunol 1987;79:442-7.
24. Hansbrough JR, Wedner HJ, Chaplin DD. Anaphylaxis to intravenous furosemide. J Allergy Clin Immunol 1987;80:538-41.
25. Ahmad A, Ramakrishnan A, McLean M, et al. Use of optical biosensor technology to study immunologic cross-reactivity between different sulfonamide drugs. Analyt Biochem 2002;300:177-84.
26. Sullivan TJ, Ong RC, Gilliam LK. Studies of the multiple drug allergy syndrome [abstr]. J Allergy Clin Immunol 1989;83:270.
27. Patterson R, Bello AE, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Ther 1999;21:2065-79.
28. Curtis BR, McFarland JG, Wu G-G, Visentin GP, Aster RH. Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood 1994;84:176-83.
29. Hess DA, Sisson ME, Suria H, et al. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole. FASEBJ 1999;13:1688-98.
30. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986;105:179-84.
31. Ozkaya-Bayazit E, Akar U. Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B12 Cw6 haplotype. J Am Acad Dermatol 2001;45:712-17.
32. Vree TB, Hekster YA. Pharmacokinetics of sulfonamides revisited. Antibiot Chemother 1985;34:1-177.
33. Vree TB, Hekster YA. Clinical pharmacokinetics of sulfonamides and their metabolites. Antibiot Chemother 1987;37:1-214.
34. Alfirevic A, Stalford AC, Viklar FJ, Wilkins EG, Park BK, Pirmohamed M. Slow acetylator phenotype and genotype in HIV-positive patients with sulfamethoxazole hypersensitivity Br J Clin Pharmacol 2003;55:158-65.
35. Gunnarsson I, Kanerud L, Pettersson E, Lundberg I, Lindblad S, Ringertz B. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus. Br J Rheumatol 1997;36:1089-94.
36. Wolkenstein P, Loriot MA, Aractingi S, Cabelguenne A, Beaune P, Chosidow O. Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS. Pharmacogenetics 200;10:821-8.
37. Walmsley SL, Winn LM, Harrison ML, Uetrecht JP, Wells PG. Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: toxicological and pathological implications. AIDS 1997;11:1689-97.
38. Strom BL, Schinnar R, Apter AJ, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. New Engl J Med 2003;349:1628-35.
39. Farrell J, Naisbitt DJ, Drummond NS, et al. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. J Pharmacol Exp Ther 2003;306:229-37.
40. Kaur C, Sarkar R, Kanwar A. Fixed drug eruption to rofecoxib with cross-reactivity to sulfonamides [letter]. Dermatology 2001;203:351.
41. Sarkar R, Kaur C, Kanwar A. Extensive fixed drug eruption to nimesulide with cross-sensitivity to sulfonamides in a child. Pediatr Dermatol 2002;6:553-4.